Maryland
Cancer clinical trials in Maryland
388 cancer studies are recruiting participants at sites in 33 cities across Maryland as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Maryland city with a recruiting study
By research area: Lung Cancer (107), Breast Cancer (85), Lymphoma (84), Prostate Cancer (68), Pancreatic Cancer (31), Melanoma (13).
Baltimore (223), Bethesda (142), Glen Burnie (22), Columbia (21), Towson (19), Bel Air (16), Frederick (15), Annapolis (14), Silver Spring (14), Largo (13), Rockville (13), Westminster (12), Elkton (11), Cumberland (10), Lutherville (10), Easton (9), Gaithersburg (8), Aberdeen (6), Clinton (6), Brandywine (5), Olney (5), Randallstown (4), Salisbury (4), Germantown (3), Ocean Pines (3), Kensington (2), Beltsville (1), Calverton (1), Catonsville (1), Hagerstown (1), Hanover (1), Hyattsville (1), Laurel (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Maryland
Basic details from each study's public record (the 12 most recently updated of 388). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
- Observational
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT07619534 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Maryland on ClinicalTrials.gov.
Lung cancer: recently updated in Maryland
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Teligene US
- Recruiting in
- Baltimore
- Registry record
- NCT05168566 · updated
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Baltimore
- Registry record
- NCT06287775 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Maryland on ClinicalTrials.gov.
Prostate cancer: recently updated in Maryland
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
- Phase 2
- Ages 18 to 120
- Male participants
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT07574541 · updated
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
- Phase 1/2
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT07667400 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Maryland on ClinicalTrials.gov.
Melanoma: recently updated in Maryland
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Phase 3
- Ages 75 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Elkton
- Registry record
- NCT07068074 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Maryland on ClinicalTrials.gov.
Lymphoma: recently updated in Maryland
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- Phase 2
- Ages 12 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT03258567 · updated
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- No phase
- Ages 1 to 25
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT05621291 · updated
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eastern Cooperative Oncology Group
- Recruiting in
- Baltimore · Elkton
- Registry record
- NCT06724237 · updated
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Recruiting in
- Silver Spring
- Registry record
- NCT07221500 · updated
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Newave Pharmaceutical Inc
- Recruiting in
- Bethesda
- Registry record
- NCT07342478 · updated
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 1
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT07572136 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Maryland on ClinicalTrials.gov.
Ask about studies in Maryland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections